These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 24258773

  • 1. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S, Kauffman R, Simpson P, Lehr VT, Lai ML, Sarniak A, Tolia V.
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [Abstract] [Full Text] [Related]

  • 2. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K, Sullivan TJ, Jauregui L.
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of ranitidine and famotidine in healthy elderly subjects: a double-blind, placebo-controlled comparison.
    Bisson C, St-Laurent M, Michaud JT, LeBel M.
    Pharmacotherapy; 1993 Dec; 13(1):3-9. PubMed ID: 8437966
    [Abstract] [Full Text] [Related]

  • 4. A randomized clinical trial comparing the efficacy of ranitidine and famotidine on intragastric acidity in critically ill pediatric patients.
    Aanpreung P, Vanprapar N, Susiva C, Parkpreaw C, Boonyachart C.
    J Med Assoc Thai; 1998 Mar; 81(3):185-9. PubMed ID: 9623009
    [Abstract] [Full Text] [Related]

  • 5. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
    Osteyee JL, Banner W.
    Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
    [Abstract] [Full Text] [Related]

  • 6. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE, West JM, Loft DE, Cottrell J, Mann SG, Stauffer L, Nwokolo CU.
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [Abstract] [Full Text] [Related]

  • 7. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL, McQuaid KR, Koss MA, Crombie DL, Hunter S, Metz C, Euler AR, Isenberg JI.
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and pharmacodynamics of famotidine in children.
    James LP, Marshall JD, Heulitt MJ, Wells TG, Letzig L, Kearns GL.
    J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
    Lugo RA, Harrison AM, Cash J, Sweeley J, Vernon DD.
    Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V, Mela GS, Zentilin P, Scalabrini P, Bonifacino G, Gambaro P, Celle G.
    Digestion; 1989 Apr; 42(1):1-6. PubMed ID: 2568299
    [Abstract] [Full Text] [Related]

  • 11. Effects of different combinations of H2 receptor antagonist with gastrokinetic drugs on gastric fluid pH and volume in children--a comparative study.
    Kulkarni PN, Batra YK, Wig J.
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):561-4. PubMed ID: 9455714
    [Abstract] [Full Text] [Related]

  • 12. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V.
    Ital J Gastroenterol; 1990 Dec; 22 Suppl 2():20-3. PubMed ID: 1983412
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P, Brabetz-Höfliger A, Bründler R, Flogerzi B, Hüsler J, Halter F.
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [Abstract] [Full Text] [Related]

  • 14. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S, Clausi GG, Farinelli M, Santucci L, Farroni F, Pelli MA, Morelli A.
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of famotidine in infants.
    James LP, Marotti T, Stowe CD, Farrar HC, Taylor BJ, Kearns GL.
    J Clin Pharmacol; 1998 Dec; 38(12):1089-95. PubMed ID: 11301560
    [Abstract] [Full Text] [Related]

  • 16. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
    Mathôt RA, Geus WP.
    Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.
    Amsden GW, Goss TF, Harrison NJ, D'Andrea DT, Schentag JJ.
    J Clin Pharmacol; 1994 Dec; 34(12):1191-8. PubMed ID: 7738215
    [Abstract] [Full Text] [Related]

  • 18. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
    Reilly TG, Singh S, Cottrell J, Mann SG, Stauffer L, Walt RP.
    Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
    [Abstract] [Full Text] [Related]

  • 19. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
    Lachman L, Howden CW.
    Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
    [Abstract] [Full Text] [Related]

  • 20. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity.
    Gardner JD, Ciociola AA, Robinson M, McIsaac RL.
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.